MoneyWorks4Me

Colinz Laboratories - Quaterly Results

31 Jan 2025 Evaluate
The sales declined to Rs. 14.66 millions for the December 2024 quarter as compared to Rs. 17.14 millions during the corresponding quarter last year.Net profit of the cmpany stood at Rs. 0.54 millions for the quarter ended December 2024 a decline of -48.57% from Rs. 1.05 millions  in the same quarter last year.The Operating Profit of the company witnessed a decrease to 1.41 millions from 1.88 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 14.66 17.14 -14.47 50.76 53.99 -5.98 70.30 71.55 -1.75
Other Income 0.77 0.48 60.42 2.22 1.68 32.14 2.75 1.72 59.88
PBIDT 1.41 1.88 -25.00 6.19 5.85 5.81 8.17 7.81 4.61
Interest 0.05 0.10 -50.00 0.26 0.27 -3.70 0.37 0.52 -28.85
PBDT 1.36 1.78 -23.60 5.93 5.58 6.27 7.80 7.29 7.00
Depreciation 0.32 0.33 -3.03 0.96 0.99 -3.03 1.30 1.29 0.78
PBT 1.04 1.45 -28.28 4.97 4.59 8.28 6.50 6.00 8.33
TAX 0.50 0.40 25.00 1.50 1.10 36.36 1.64 1.42 15.49
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.12 -0.16 -25.00
PAT 0.54 1.05 -48.57 3.47 3.49 -0.57 4.86 4.58 6.11
Equity 25.19 25.19 0.00 25.19 25.19 0.00 25.19 25.19 0.00
PBIDTM(%) 9.62 10.97 -12.31 12.19 10.84 12.55 11.62 10.92 6.47
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..